Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
beLP3-D-Bereum-postbiotic
- Development stage
- Preclinical
- Lead developer
- Bereum
- Modality
- Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
01
Overview
beLP3-D-Bereum-postbiotic is a three-strain mixed powder postbiotic formulation developed by Bereum. It contains heat-treated (tyndallized) *Lactobacillus plantarum*, *Lactobacillus casei*, and *Lactobacillus acidophilus*, with maltodextrin serving as a carrier. As a postbiotic, it consists of inanimate microorganisms and their components that provide physiological benefits to the host, such as supporting gut health and modulating immune responses. This formulation is designed as a functional raw material for use in dietary supplements and health-focused food products, leveraging the synergistic effects of multiple lactic acid bacteria strains.
- Other names
- 3-strain Mixed PowderLactobacillus plantarum + Lactobacillus casei + Lactobacillus acidophilus + Maltodextrin
Beyond the preview
Go deeper on beLP3-D-Bereum-postbiotic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on beLP3-D-Bereum-postbiotic.